FDA.reportPublic FDA data

Application 202772

Type
ANDA
Sponsor
MYLAN LABS LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001NORETHINDRONE ACETATE AND ETHINYL ESTRADIOLETHINYL ESTRADIOL; NORETHINDRONE ACETATETABLET;ORAL-280.02MG;1MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0378-7283NORETHINDRONE ACETATE AND ETHINYL ESTRADIOLnorethindrone acetate and ethinyl estradiolMylan Pharmaceuticals Inc.ANDACurrent
0378-7283NORETHINDRONE ACETATE AND ETHINYL ESTRADIOLnorethindrone acetate and ethinyl estradiolMylan Pharmaceuticals Inc.ANDACurrent
0378-7283NORETHINDRONE ACETATE AND ETHINYL ESTRADIOLnorethindrone acetate and ethinyl estradiolMylan Pharmaceuticals Inc.ANDACurrent
0378-7283NORETHINDRONE ACETATE AND ETHINYL ESTRADIOLnorethindrone acetate and ethinyl estradiolMylan Pharmaceuticals Inc.ANDACurrent
50090-2478NORETHINDRONE ACETATE AND ETHINYL ESTRADIOLnorethindrone acetate and ethinyl estradiolA-S Medication SolutionsANDACurrent
50090-3395NORETHINDRONE ACETATE AND ETHINYL ESTRADIOLnorethindrone acetate and ethinyl estradiolA-S Medication SolutionsANDACurrent
50102-128TARINA Fe 1/20norethindrone acetate and ethinyl estradiolAfaxys Pharma, LLC.ANDACurrent
50102-128TARINA Fe 1/20norethindrone acetate and ethinyl estradiolAfaxys Pharma, LLC.ANDACurrent
50102-128TARINA Fe 1/20norethindrone acetate and ethinyl estradiolAfaxys Pharma, LLC.ANDACurrent
53002-1711TARINA Fe 1/20norethindrone acetate and ethinyl estradiolRPK Pharmaceuticals, Inc.ANDACurrent
53002-1711TARINA Fe 1/20norethindrone acetate and ethinyl estradiolRPK Pharmaceuticals, Inc.ANDACurrent